LOVE.CN - Cannara Biotech Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.1400
-0.0250 (-15.15%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.1650
Open0.1650
Bid0.1400 x 0
Ask0.1450 x 0
Day's Range0.1250 - 0.1700
52 Week Range0.0500 - 0.2050
Volume2,211,913
Avg. Volume479,024
Market Cap97.268M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0120
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce

    Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce

  • CNW Group

    IIROC Trade Resumption - LOVE

    IIROC Trade Resumption - LOVE

  • CNW Group

    Cannara Biotech Submits Site Evidence Package to Health Canada for its Quebec Facility

    VANCOUVER , Sept. 12, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (LOVE.CN) (OTCQB:LOVFF) (8CB.F), an emerging vertically integrated cannabis company focused on indoor cultivation and sale of  premium cannabis and cannabis-infused products, announced it has submitted to Health Canada its site evidence package for Phase One of the Company's cultivation and processing facility in Farnham, Quebec . With construction recently completed, Phase One consists of 170,000 square feet, of which 110,000 is dedicated to indoor cultivation with a capacity of 20,000 kg of premium dried cannabis once the cultivation license is granted. The facility is situated on 27-acres of land located 45 minutes from Montreal and both the facility and the license are held through wholly owned subsidiaries of Cannara Biotech Inc.

  • CNW Group

    IIROC Trading Halt - LOVE

    IIROC Trading Halt - LOVE

  • CNW Group

    Cannara Announces Appointment of New Chief Operating Officer

    Cannara Announces Appointment of New Chief Operating Officer

  • CNW Group

    OTCQB Venture Company Investor Presentations Now Available for On-Demand Viewing

    OTCQB Venture Company Investor Presentations Now Available for On-Demand Viewing

  • PR Newswire

    Cannara Biotech to Webcast Live at VirtualInvestorConferences.com August 1

    Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com VANCOUVER, British Columbia , ...

  • CNW Group

    Live OTCQB Venture Company Investor Conference August 1st

    Live OTCQB Venture Company Investor Conference August 1st

  • CNW Group

    Cannara Biotech Inc. Reports Q3 2019 Results

    VANCOUVER , July 25, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (LOVE.CN) (8CB.F) (OTCQB:LOVFF), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried premium cannabis and cannabis-infused products, today announced financial results for the three month and nine month periods ended May 31, 2019. Closed a Global shopCBD.com Inc. financing in excess of $8 million to support the launch of the online e-commerce platform for the sale and distribution, in the US, of hemp-based CBD products. Subsequent to the quarter, the Company further strengthened its balance sheet with a $2.1 million private placement.

  • CNW Group

    Cannara Biotech Announces Non-Brokered Private Placement of 12,000,000 Common Shares

    Cannara Biotech Announces Non-Brokered Private Placement of 12,000,000 Common Shares

  • CNW Group

    Horizons ETFs Rebalances Marijuana-Focused ETFs

    Horizons ETFs Rebalances Marijuana-Focused ETFs

  • Market Exclusive

    Cannabis Stock News Daily Roundup May 28

    CannTrust Holdings (TSX: TRST) (NYSE: CTST) has launched a cannabis education portal together with Well.ca. The resource is available to Ontario residents through Well.ca with additional provinces to launch soon. Well.ca will serve as a resource and education center for those interested in exploring medical cannabis, leveraging content, insights and expertise from CannTrust's medical business. […]The post Cannabis Stock News Daily Roundup May 28 appeared first on Market Exclusive.

  • CNW Group

    Cannara Biotech Appoints Dr. Sara May to its Board of Directors

    VANCOUVER , May 24, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (LOVE.CN) (8CB.F) (CNBTF), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the appointment of Dr. Sara May , PhD. Dr. May is recognized as an expert in the medical cannabis sector and will bring  additional skill sets and help strengthen  the Company's Board.

  • PR Newswire

    Cannara Biotech Commences Trading on the OTCQB Market in the United States

    VANCOUVER, May 15, 2019 /PRNewswire/ - Cannara Biotech ("Cannara" or the "Company") (LOVE.CN) (8CB.F) (CNBTF), an emerging vertically integrated cannabis company focused on the cultivation and sale of cannabis and cannabis-infused products to the Canadian and international markets, today announced its common shares are listed for trading on the OTCQB® Venture Market under the  trading symbol "CNBTF". The OTC operates financial markets for approximately 10,000 U.S. and global securities.  "Cannabis and hemp-CBD markets are global markets, with customers, vendors and investors domiciled across all major industrial nations," said Zohar Krivorot, President and CEO of Cannara.

  • GlobeNewswire

    PSIQ ANNOUNCES RESELLER AGREEMENT WITH CANNARA BIOTECH SUBSIDIARY SHOPCBD.COM TO MARKET AND SELL ELITES CBD PRODUCT LINE WITHIN THE UNITED STATES

    SUNRISE, Fla., April 30, 2019 -- Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that its wholly owned subsidiary, Elite Products International, Inc. (“Elite”), has.